Skip to content

Drug interactions

Anakinra + Tisagenlecleucel

Severity: Moderate

Anakinra and Tisagenlecleucel: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Anakinra is used off-label to manage CAR-T cytokine release syndrome and neurotoxicity, so the pairing is often intentional. The main concerns are added infection risk and a theoretical effect on CAR-T expansion and activity.

What this interaction means in plain words

Anakinra and Tisagenlecleucel can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Anakinra belongs to Musculoskeletal; Tisagenlecleucel belongs to Oncology.

Evidence level: Low

Why it happens

IL-1 blockade may dampen inflammatory signaling and add to immunosuppression; effect on CAR-T efficacy is not firmly established.

What to do

Use anakinra for CAR-T toxicity only under specialist oversight and monitor for infection and for response of the underlying malignancy.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Anakinra and Tisagenlecleucel, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Anakinra with Tisagenlecleucel?

MediHelp rates the interaction as moderate. Anakinra and Tisagenlecleucel can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Anakinra is used off-label to manage CAR-T cytokine release syndrome and neurotoxicity, so the pairing is often intentional. The main concerns are added infection risk and a theoretical effect on CAR-T expansion and activity.

How serious is the interaction between Anakinra and Tisagenlecleucel?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Use anakinra for CAR-T toxicity only under specialist oversight and monitor for infection and for response of the underlying malignancy.

What other medicines interact with Anakinra?

MediHelp also lists interactions of Anakinra with, for example, Bcg vaccine live, Measles mumps and rubella vaccine, Measles mumps and rubella vaccine live. The full list is on the Anakinra page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in